The revival in stocks, though off to a bumpy start in December, has been broad in reach, pulling up shares of everything from small caps to cyclical stocks
The US health agency Centers for Disease Control and Prevention (CDC) on Tuesday authorized, approved, and recommended everyone above the age of 6 months to get an updated COVID-19 booster.
This decision is taken by the CDC as well as the Food and Drug Administration (FDA), calling it a historic progress President Joe Biden said that it is an “important” milestone.
According to an official White House release, Biden said, “Since entering office, my Administration has made historic progress in our ability to manage COVID-19 so that it no longer meaningfully disrupts our lives.”
“Today marks another important milestone. Following an independent scientific review, the Food and Drug Administration and the Centers for Disease Control and Prevention have now authorized, approved, and recommended everyone 6 months and older get an updated COVID-19 vaccine to protect against serious illness this fall and winter,” he added.
The White House release stated that now have vaccines for all three primary seasonal respiratory viruses – COVID-19, flu, and RSV.
“As we enter the autumn and winter seasons, we are in the best possible position, with more tools and systems than ever before, including safe and effective immunisations, widely available at-home testing, and effective treatments,” White House release said.
Vaccination against COVID-19 is still the most effective way to avert hospitalisation, long-term health consequences, and death.
“I urge all Americans to keep their immunisations up to date,” the US President said.
Apparently, new Covid-19 variant EG.5 is on the rise in the US. The variant is causing about 17 per cent of the new Covid-19 cases in the country compared to 16 per cent for the next most common lineage, XBB.1.16, according to the latest estimates from the US Centers for Disease Control and Prevention, CNN reported.
The new variant is a spinoff of the XBB recombinant strain of the Omicron family.
EG.5, compared to its parent XBB.1.9.2, has one extra mutation to its spike, at position 465. This mutation has appeared in other coronavirus variants before.
Scientists are still not aware what the new mutation enables the virus to do.
The 465 mutation is present in about 35 per cent of coronavirus sequences reported worldwide, including another that’s rising in prevalence in the Northeast, FL.1.5.1, suggesting that it is conveying some kind of evolutionary advantage over previous versions, as per CNN.
EG.5 now has its own offshoot, EG.5.1, that adds a second mutation to the spike. That one is also spreading rapidly.